Sanofi has signed a rights deal with Roche for the rights to Tamiflu in the United States.
The deal will give Sanofi exclusive over-the-counter rights to the flu prevention treatment.
According to Sanofi's head of consumer healthcare, this move is strategic and important.
Read the Reuters report.